338 related articles for article (PubMed ID: 16701094)
41. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
[TBL] [Abstract][Full Text] [Related]
42. Sentinel node biopsy for breast cancer larger than 3 cm in diameter.
Schüle J; Frisell J; Ingvar C; Bergkvist L
Br J Surg; 2007 Aug; 94(8):948-51. PubMed ID: 17436338
[TBL] [Abstract][Full Text] [Related]
43. Is a lymph node detected by the dye-guided method a true sentinel node in gastric cancer?
Osaka H; Yashiro M; Sawada T; Katsuragi K; Hirakawa K
Clin Cancer Res; 2004 Oct; 10(20):6912-8. PubMed ID: 15501969
[TBL] [Abstract][Full Text] [Related]
44. Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.
Boneti C; Korourian S; Bland K; Cox K; Adkins LL; Henry-Tillman RS; Klimberg VS
J Am Coll Surg; 2008 May; 206(5):1038-42; discussion 1042-4. PubMed ID: 18471751
[TBL] [Abstract][Full Text] [Related]
45. Factors affecting false-negative breast sentinel node biopsy in Chinese patients.
Chok KS; Suen DT; Lim FM; Li GK; Kwong A
ANZ J Surg; 2007 Oct; 77(10):866-9. PubMed ID: 17803550
[TBL] [Abstract][Full Text] [Related]
46. Preoperative lymphatic mapping does not predict the number of axillary sentinel lymph nodes identified during surgery in breast cancer patients.
Carmon M; Hain D; Shapira J; Golomb E
Breast J; 2006; 12(5):424-7. PubMed ID: 16958959
[TBL] [Abstract][Full Text] [Related]
47. Comparison of peritumoral and subareolar injection of Tc99m sulphur colloid and blue-dye for detection of the sentinel lymph node in breast cancer.
Jastrzebski T; Kopacz A; Lass P
Nucl Med Rev Cent East Eur; 2002; 5(2):159-61. PubMed ID: 14600877
[TBL] [Abstract][Full Text] [Related]
48. [Sentinel lymph node biopsy in breast cancer].
Schlichting E; Harr ME; Sauer T; Babovic A; Kåresen R
Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2098-100. PubMed ID: 16932777
[TBL] [Abstract][Full Text] [Related]
49. Sentinel node biopsy in breast cancer: five years experience from Denmark.
Christiansen P; Friis E; Balslev E; Jensen D; Møller S;
Acta Oncol; 2008; 47(4):561-8. PubMed ID: 18465323
[TBL] [Abstract][Full Text] [Related]
50. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
51. Lymphatic mapping improves staging and reduces morbidity in women undergoing total mastectomy for breast carcinoma.
Langer S; Guenther JM; Haigh PI; Difronzo LA
Am Surg; 2004 Oct; 70(10):881-5. PubMed ID: 15529842
[TBL] [Abstract][Full Text] [Related]
52. Sentinel node biopsy in larger or multifocal breast cancers: to do or not to do.
Behm EC; Buckingham JM
ANZ J Surg; 2008 Mar; 78(3):151-7. PubMed ID: 18269478
[TBL] [Abstract][Full Text] [Related]
53. Sentinel node mapping for gastric cancer.
Rabin I; Chikman B; Halpern Z; Wassermann I; Lavy R; Gold-Deutch R; Sandbank J; Halevy A
Isr Med Assoc J; 2006 Jan; 8(1):40-3. PubMed ID: 16450751
[TBL] [Abstract][Full Text] [Related]
54. Sentinel lymph node biopsy for breast cancer: improvement in results over time.
Chao C; Wong SL; Tuttle TM; Noyes RD; Carlson DJ; Ley P; McGlothin T; Laidley A; Simpson D; Edwards MJ; McMasters KM;
Breast J; 2004; 10(4):337-44. PubMed ID: 15239793
[TBL] [Abstract][Full Text] [Related]
55. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
56. Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.
Hidar S; Bibi M; Gharbi O; Tebra S; Trabelsi A; Korbi S; Bouaouina N; Ben Ahmed S; Khaïri H
Int J Surg; 2009 Jun; 7(3):272-5. PubMed ID: 19410665
[TBL] [Abstract][Full Text] [Related]
57. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.
Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM
J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961
[TBL] [Abstract][Full Text] [Related]
58. Combination of subareolar blue dye and peritumoral RI for sentinel lymph node biopsy.
Tsunoda N; Iwata H; Sarumaru S; Mizutani M; Iwase T; Miura S
Breast Cancer; 2002; 9(4):323-8. PubMed ID: 12459714
[TBL] [Abstract][Full Text] [Related]
59. [Sentinel node in the surgical treatment of the breast cancer. Technique and clinical experience].
Freda F; Fabbrocile G; Antropoli M; Manganiello A; Nunziata L; Petronella P
Minerva Chir; 2005 Aug; 60(4):235-41. PubMed ID: 16166922
[TBL] [Abstract][Full Text] [Related]
60. The role of subareolar blue dye in identifying the sentinel node in patients with invasive breast cancer.
Mokbel K; Mostafa A
Curr Med Res Opin; 2001; 17(2):93-5. PubMed ID: 11759188
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]